Tumours have developed many strategies and tricks to gain advantages in the body. Led by cell biology professor Sabine Werner, researchers at ETH Zurich have now discovered another surprising trick ...

Researchers found that IgG1 plasma cells and antibody levels may predict response to PD-1 inhibitor immunotherapy, based on a ...

Experts discuss the small but promising study.

Cancer cells provide healthy neighboring cells with additional mitochondria to put them to work. This has been demonstrated by researchers at ETH Zurich in a new study. In this way, cancer is ...

For almost 60 years, scientists have tried to understand why DNA doesn't replicate wildly and uncontrollably every time a ...

The segment spotlighted the Baylor-led research recently published in Nature Medicine evaluating autologous Multi-Antigen Targeted T cell therapy in patients with pancreatic ductal adenocarcinoma ...

Cancer doesn’t evolve by pure chaos. Scientists have developed a powerful new method that reveals the hidden rules guiding how cancer cells gain and lose whole chromosomes—massive genetic shifts that ...

Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...

A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers at the University of Southampton have identified a new strategy that could ...

Scientists at Oregon State University have developed a new nanomaterial that triggers a pair of chemical reactions inside ...